219 related articles for article (PubMed ID: 2479168)
1. Identification of amino acid residues important to the neuraminidase activity of the HN glycoprotein of Newcastle disease virus.
Iorio RM; Syddall RJ; Glickman RL; Riel AM; Sheehan JP; Bratt MA
Virology; 1989 Nov; 173(1):196-204. PubMed ID: 2479168
[TBL] [Abstract][Full Text] [Related]
2. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment.
Iorio RM; Glickman RL; Riel AM; Sheehan JP; Bratt MA
Virus Res; 1989 Jul; 13(3):245-61. PubMed ID: 2475989
[TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution in the hemagglutinin-neuraminidase of Newcastle disease virus results in a protein deficient in both functions.
Sheehan JP; Iorio RM
Virology; 1992 Aug; 189(2):778-81. PubMed ID: 1641990
[TBL] [Abstract][Full Text] [Related]
4. Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus.
Yusoff K; Nesbit M; McCartney H; Emmerson PT; Samson AC
Virus Res; 1988 Nov; 11(4):319-33. PubMed ID: 2464879
[TBL] [Abstract][Full Text] [Related]
5. Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition.
Iorio RM; Syddall RJ; Sheehan JP; Bratt MA; Glickman RL; Riel AM
J Virol; 1991 Sep; 65(9):4999-5006. PubMed ID: 1651419
[TBL] [Abstract][Full Text] [Related]
6. Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus.
Gotoh B; Sakaguchi T; Nishikawa K; Inocencio NM; Hamaguchi M; Toyoda T; Nagai Y
Virology; 1988 Mar; 163(1):174-82. PubMed ID: 2450424
[TBL] [Abstract][Full Text] [Related]
7. Fusion mutants of Newcastle disease virus selected with monoclonal antibodies to the hemagglutinin-neuraminidase.
Iorio RM; Glickman RL
J Virol; 1992 Nov; 66(11):6626-33. PubMed ID: 1404607
[TBL] [Abstract][Full Text] [Related]
8. Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein.
Hu S; Wang T; Liu Y; Meng C; Wang X; Wu Y; Liu X
Vet Microbiol; 2010 Jan; 140(1-2):92-7. PubMed ID: 19729254
[TBL] [Abstract][Full Text] [Related]
9. Amino acid substitutions in a conserved region in the stalk of the Newcastle disease virus HN glycoprotein spike impair its neuraminidase activity in the globular domain.
Wang Z; Iorio RM
J Gen Virol; 1999 Mar; 80 ( Pt 3)():749-753. PubMed ID: 10092015
[TBL] [Abstract][Full Text] [Related]
10. Roles of the highly conserved amino acids in the globular head and stalk region of the Newcastle disease virus HN protein in the membrane fusion process.
Sun C; Wen H; Chen Y; Chu F; Lin B; Ren G; Song Y; Wang Z
Biosci Trends; 2015 Feb; 9(1):56-64. PubMed ID: 25787910
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites.
Iorio RM; Bratt MA
J Immunol; 1984 Oct; 133(4):2215-9. PubMed ID: 6470488
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of fusion by neutralizing monoclonal antibodies to the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.
Iorio RM; Glickman RL; Sheehan JP
J Gen Virol; 1992 May; 73 ( Pt 5)():1167-76. PubMed ID: 1375279
[TBL] [Abstract][Full Text] [Related]
13. Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants.
Thompson SD; Portner A
Virology; 1987 Sep; 160(1):1-8. PubMed ID: 2820122
[TBL] [Abstract][Full Text] [Related]
14. The role of the individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus.
McGinnes LW; Morrison TG
Virology; 1994 May; 200(2):470-83. PubMed ID: 8178436
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt.
Moharam I; Asala O; Reiche S; Hafez H; Beer M; Harder T; Grund C
Virol J; 2021 Apr; 18(1):86. PubMed ID: 33902633
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel E347Q and G362K amino acid substitutions in HN neutralization epitope and major antigenic difference in novel sub-genotype VIIj isolates.
Mayahi V; Esmaelizad M
Acta Virol; 2017; 61(4):438-444. PubMed ID: 29186960
[TBL] [Abstract][Full Text] [Related]
17. Characterization of reference strains of Newcastle disease virus (NDV) and NDV-like isolates by monoclonal antibodies to HN subunits.
Ishida M; Nerome K; Matsumoto M; Mikami T; Oya A
Arch Virol; 1985; 85(1-2):109-21. PubMed ID: 2409954
[TBL] [Abstract][Full Text] [Related]
18. Location of amino acid residues important for the structure and biological function of the haemagglutinin-neuraminidase glycoprotein of Sendai virus by analysis of escape mutants.
Lyn D; Mazanec MB; Nedrud JG; Portner A
J Gen Virol; 1991 Apr; 72 ( Pt 4)():817-24. PubMed ID: 1849969
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
[TBL] [Abstract][Full Text] [Related]
20. Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells
Rangaswamy US; Wang W; Cheng X; McTamney P; Carroll D; Jin H
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
